Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 830 of 6351
-
Could a blood pressure drug help treat PTSD and alcohol addiction together?
Symptom relief CompletedThis study evaluates the therapeutic tolerability of the use of Cognitive Processing Therapy (CPT) with propranolol in participants with Posttraumatic Stress Disorder (PTSD) and Alcohol Use Disorder (AUD). The investigators are planning to perform an initial proof -of- concept ra…
Phase 2 • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Diabetes drug shows promise for rare immune disorder
Disease control CancelledEmpagliflozin Treatment of GSD-1b patients
Phase 2 • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain scans could make TMS for depression more precise
Symptom relief CompletedThe goal of this clinical trial is to estimate the importance of neuroimaging in accelerated intermittent theta burst stimulation (aiTBS) for depression. Participants will receive aiTBS treatment, but they will not know if their treatment spot was found with neuroimaging or head …
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
New maintenance therapy shows promise in preventing T-Cell cancer relapse after transplant
Disease control CompletedClinical Study on the Safety and Effectiveness of low-dose chidamide maintenance therapy after allogeneic hematopoietic stem cell transplantation for T-cell acute lymphoblastic leukemia or T-cell lymphomas.
Phase 2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug combo aims to keep HER2+ esophageal cancer from coming back
Disease control OngoingAn open label phase II study to determine the safety and preliminary efficacy of the combination of 1-year of adjuvant trastuzumab deruxtecan and nivolumab for patients with HER2 overexpressing esophagogastric adenocarcinoma who have completed chemoradiation followed by esophagec…
Phase 2 • Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Virtual counseling may help mothers facing a fetal heart defect
Symptom relief CompletedCongenital heart disease (CHD) is the most common birth defect and is increasingly diagnosed prenatally. Mothers describe their prenatal experiences as highly stressful and traumatic after a diagnosis of CHD. Maternal stress during pregnancy exerts a powerful influence on birth o…
Sponsor: Nemours Children's Clinic • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New drug combo may replace harsh transplant for hodgkin lymphoma patients
Disease control OngoingThis trial investigates the efficacy and safety of the drug tislelizumab in combination with chemotherapy as a treatment for patients with R/R HL. Tislelizumab is given in combination with chemotherapy (gemcitabine and cisplatin) followed by consolidation with tislelizumab alone.…
Phase 2 • Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New stroke drug shows promise in major trial
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of redasemtide in adult participants with acute ischemic stroke (AIS). This study consists of 2 cohorts, Cohort A and Cohort B. Cohort A (redasemtide or placebo) will enroll participants who are ineligible for syste…
Phase 2 • Sponsor: Shionogi • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New hope for kids with hard-to-treat leukemia: combo therapy trial opens
Disease control Recruiting nowTo learn if cyclophosphamide, vincristine, and dexamethasone (called mini hyper-CVD) in combination with intrathecal (delivered into the spine) chemotherapy (methotrexate, hydrocortisone, cytarabine) and compressed rituximab, blinatumomab, and inotuzumab ozogamicin (called cRIB) …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New hope for rare kidney disease: eculizumab trial shows promise in china
Disease control CompletedThis is a Phase 3b, open-label, single-arm, multicenter study to evaluate the efficacy and safety of eculizumab in participants with atypical hemolytic uremic syndrome (aHUS) in China
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a vacuum dressing slash infection rates after major abdominal surgery?
Disease control OngoingPost-operative wound issues in abdominal surgery have a significant impact on patient outcomes. This study is taking place to investigate if Negative Pressure Wound Therapy (NPWT) dressings reduces Surgical Site Infections, post surgical complications and improves scar appearance…
Sponsor: Royal College of Surgeons, Ireland • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Tuning up CAR t: can a better prep boost lymphoma remission?
Disease control Recruiting nowThis is a Phase 1b study of participants with Diffuse Large B Cell Lymphoma (DLBCL). The purpose of this study is to identify an optimized lymphodenpletion (LD) regimen by evaluating standard and intermediate doses of Fludarabine (Flu) / Cyclophosphamide (Cy) with or without a fi…
Phase 1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can tumor DNA and immune cells reveal why some cancers resist immunotherapy?
Knowledge-focused OngoingThe goal of this investigator-initiated tumour profiling study is to analyse the relation between genomic alterations and the tumour immune contexture in patients with advanced melanoma and pancreatic cancer with resistance to (immuno)therapy, aiming to identify targets and appro…
Sponsor: Amsterdam UMC, location VUmc • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Cancer cocktail shows promise in early trial
Disease control OngoingThis is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 study to evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1 antibody-based SoC therapy in adult patients with solid tumors.
Phase 2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New study aims to curb suicide in LGBTQ+ youth via primary care
Symptom relief Recruiting nowThe overall aim of this study is to reduce suicide among sexual and gender diverse youth ages 18-24 years old. This study will compare the effectiveness of two brief suicide prevention interventions that have been adapted for use with this population to use in primary care via te…
Sponsor: Elizabeth Arnold • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New drug combo aims to shrink tough lung tumors
Disease control OngoingThis trial is a Phase Ib/II study. All patients are stage IIIB/C (unsuitable for radical therapy) or IV non-small cell lung cancer(NSCLC), Eastern Cooperative Oncology Group (ECOG) performance status 0-1. The purpose of this study is to evaluate the safety and efficacy of AK112 a…
Phase 1/2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Your voice may reveal Alzheimer's: no needles needed
Diagnosis Recruiting nowPLATA aims to develop an algorithm to identify vocal biomarkers of Alzheimer's dementia. Using data collected as part of routine care, speech patterns will be compared to known biomarkers of Alzheimer's disease, such as amyloid 1-42 and p-Tau in CSF (cerebrospinal fluid). If bi…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Brain health boost: yoga, music, and diet may ward off neurological disorders
Prevention OngoingThis clinical trial aims to test the impact of multidisciplinary lifestyle interventions (MLI) in neurologically healthy but at-risk individuals. It aims to find out: * if giving four different kinds of lifestyle intervention and education slows down or reverses the expression o…
Sponsor: Vineet Punia MD • Aim: Prevention
Last updated Jul 12, 2026 00:00 UTC
-
Smartwatch study could change how millions take blood thinners
Disease control Recruiting nowREACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation (DOAC) use versus time-delimited (1 month) DOAC guided by an AF-sensing Smart Wa…
Phase 3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
AI-Powered stethoscope aims to spot hidden Heart-Lung disease
Diagnosis Recruiting nowThe major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefor…
Sponsor: Eko Devices, Inc. • Aim: Diagnosis
Last updated Aug 26, 2026 00:00 UTC